Skip to content
Government Federal, Medical Health Aged Care

Public health community thunderstruck as ACDC bills pass Senate

Public Health Association of Australia 2 mins read

5 November 2025

 

Public health groups are delighted that legislation to create an Australian Centre for Disease Control – the most important piece of public health infrastructure in generations – has today passed the Senate and can start next year.

“Thanks to the many people who’ve put in hard work and long nights, showing it’s a long way to the top to get a Centre for Disease Control,” Adj Prof Terry Slevin, CEO, Public Health Association of Australia, says.

“This is a moment for the public health history books, and is testament to the tenacity of countless people who’ve toiled for decades to achieve this.

“This centre will save lives, not just here but also overseas as it will increase our links with our neighbours.

“Thank you not just the members and senators who voted in favour of the bills, but also their advisers. We also thank the tireless public servants who have dedicated more than three years to turn this idea into a reality. They patiently took our calls, read our emails, and listened to briefings by ourselves and many other individuals and groups from the health and medical communities.”

This has been a collective effort which dates to the late 1980s. A CDC was also a recommendation in Australia’s COVID-19 Response Inquiry.

The interim Australian Centre for Disease Control, which began in January 2024, will become a permanent agency effective 1 January 2026.

“An Australian CDC is now more important than ever,” Adj Prof Slevin says.

“Childhood vaccination rates are falling, misinformation is rife, the health harms from climate change are growing, and our country faces new and old infectious disease threats. The tsunami of preventable chronic disease must also be addressed.

“A permanent Australian CDC will ensure we are better prepared for future pandemics by providing a central body to coordinate and co-operate with states and territories. It will be a central source of up-to-date information and expertise across a range of health issues. It will also engage with other similar bodies around the world to gather and share intelligence.

“We also expect the Australian CDC to take leadership to help our country tackle the growing burden of preventable chronic disease.

“The Australian CDC will provide evidence based independent frank and fearless advice to the Australian government, state and territory governments, and the wider community on key public health issues.

“Today, Australia’s Parliament has helped the government to make a major, positive advance for the public’s health. We look with sadness at what the US Government is doing to dismantle its CDC and attack independent, objective science. We are thankful our parliament and our government has shown their commitment to boost Australia’s health and expert scientific information, and we applaud them.”

“This is a very good day for the health of current and future generations of people in Australia.” ENDS


About us:

About the Public Health Association of Australia

We’re Australia's peak body for public health, and advocate for the health and wellbeing of everyone. We strive to help prevent – rather than cure – illness and disease. We represent around 2,000 individual members from more than 40 professional groups interested in the promotion of public health. We have branches in every state and territory. Learn more at https://www.phaa.net.au/


Contact details:

For further information/comment: Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected]  

Media

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Government Federal
  • 05/12/2025
  • 12:07
Doctors Reform Society

Specialist Fees Denying Patient Access to Care: Time to Act

Specialist Fees Denying Patient Access to Care: Time to Act “Reports that specialist fees are skyrocketing and reducing access of patients to specialist care are very concerning and long in the making” said Dr Tim Woodruff, President, Doctors Reform Society. “The Federal Government has been very slow to act on this issue despite repeated advice””, said Dr Woodruff. “We have long recommended dedicated federal funding to state governments to be used specifically to increase their specialist outpatient facilities, with the amount based on measured need in the community. We have also recently recommended that community specialist medical centres should be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.